Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.220
-0.065 (-5.06%)
At close: May 15, 2025, 4:00 PM
1.240
+0.020 (1.64%)
After-hours: May 15, 2025, 5:28 PM EDT
Intelligent Bio Solutions Employees
Intelligent Bio Solutions had 50 employees as of June 30, 2024. The number of employees decreased by 1 or -1.96% compared to the previous year.
Employees
50
Change (1Y)
-1
Growth (1Y)
-1.96%
Revenue / Employee
$58,729
Profits / Employee
-$205,258
Market Cap
8.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INBS News
- 12 hours ago - Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing - GlobeNewsWire
- 2 days ago - Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements - GlobeNewsWire
- 9 days ago - Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion - GlobeNewsWire
- 23 days ago - Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - GlobeNewsWire